HOWE JILL ANN (Chief Financial Officer) purchased 10.50K shares of LINEAGE CELL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.3K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/19/2024ACC: 0000950170-24-098731
Officer· Chief Financial Officer
Since Mar 2026
+10.50K
Net shares
Net buyer
$9.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10.50K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+10.50K
Price / share
$0.89
Trade value
$9.35K
% of position
New position
8/16/2024
0.00→10.50K
Total
Net shares
+10.50K
Net value
$9.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/16/2024 | P · Purchase | +10.50K | $0.89 | $9.35K | New position | 0.00 | 10.50K |
| Total | +10.50K | $9.35K | ||||||
Derivative Transactions0
No derivative transactions reported